Used in pharmaceutical research as a chiral intermediate for synthesizing bioactive molecules, particularly in the development of receptor antagonists targeting inflammatory and immune-related diseases. Its structure supports high selectivity in binding to specific protein targets, making it valuable in optimizing drug candidates for improved metabolic stability and potency. Commonly employed in structure-activity relationship (SAR) studies due to the influence of trifluoromethyl groups on lipophilicity and electron-withdrawing effects.